首页> Clinical and translational allergy> Omalizumab for successful chemotherapy desensitisation: What we know so far.

Omalizumab for successful chemotherapy desensitisation: What we know so far.

导出 OA

翻译打印收藏纠错

第一作者： Roxana Silvia,Bumbacea

第一单位： "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;Department of Allergy and Clinical Immunology "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest Romania.

作者： Roxana Silvia,Bumbacea ^[1] ; Selda,Ali ^[1] ; Sabina Loredana,Corcea ^[2] ; Luiza,Spiru ^[3] ; Cornelia,Nitipir ^[4] ; Victor,Strambu ^[5] ; Dragos,Bumbacea ^[6]

作者单位： "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;Department of Allergy and Clinical Immunology "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest Romania. ^[1] Novomedica Center of Excellence Bucharest Romania. ^[2] "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;The Excellence Memory Center and Longevity Medicine "Ana Aslan" International Foundation Bucharest Romania. ^[3] "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;Department of Oncology Elias University Emergency Hospital Bucharest Romania. ^[4] "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;Department of General Surgery "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest Romania. ^[5] "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.;Department of Pneumology and Acute Respiratory Care Elias Emergency University Hospital Bucharest Romania. ^[6]

关键词 chemotherapy hypersensitivity drug desensitisation omalizumab

DOI 10.1002/clt2.12086

PMID 34938440

发布时间 2023-09-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交